Biosafety
Thinking About the Box: Considerations for Transport of Investigational Products
Ensure safe transport of investigational products with meticulous planning and rigorous procedures to mitigate hazards and uphold biosafety.
How Centralized IBC Review Can Benefit Gene Therapy Research
Understand the risks and regulatory requirements for gene therapy research and how a biosafety review can benefit this type of research.
Reporting Unexpected Incidents to the IBC
Find out which unexpected events you should report to the IBC during a clinical trial, and what to expect from the IBC's review.
A Guide for Successful Cell and Gene Therapy Research
Understand the unique regulatory, clinical, and manufacturing requirements for cell and gene therapy research.
Clean Bench vs Biosafety Cabinet: What’s the Difference?
Using hoods with biological materials depends on directional airflow, and specialized airflow is necessary when handling hazardous materials.
A Changing World in Gene Therapy Research: Exciting Opportunities for Medical Advancement and Biosafety Challenges
Our IBC experts authored the article “A Changing World in Gene Therapy Research: Exciting Opportunities for Medical Advancement and Biosafety...
Q&A Part 1 – Gene Therapy Research in the Age of COVID-19
Panelists from Advarra’s inaugural virtual symposium participated in a Q&A session to address questions submitted by the audience. Read part 1:
Q&A Part 2 – Gene Therapy Research in the Age of COVID-19
Expert panelists from Advarra’s gene therapy virtual symposium address some of the most popular questions submitted by the audience. Read part 2:
Safety Precautions for Laboratory Research With COVID-19 Specimens
The pandemic has brought biosafety to the spotlight. This blog discusses guidelines and safety precautions for handling COVID-19 specimens.
How Sites Can Prepare for COVID-19 Genetically Engineered Vaccine Studies
Is your site prepared to participate in COVID-19 vaccine research? Registering an IBC ahead of time gives you an advantage. Read more:
Key Biosafety Considerations for Coronavirus Research
Advarra Director of Biosafety Daniel Eisenman reviews opportunities, risks, and risk mitigation strategies for coronavirus research. Read more:
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.